baber/WOPTO huggingface dataset:
Patent DE-69535677-D1 (DE)
Inventor: FARMER JOSEPH C
IPC: B01J49/00
Filed: 1995-05-19
Granted: 2008-02-14
Abstract: An electrochemical cell for capacitive deionization and electrochemical purification and regeneration of electrodes includes two oppositely disposed, spaced-apart end plates, one at each end of the cell. Two generally identical single-sided end electrodes, are arranged one at each end of the cell, adjacent to the end plates. An insulator layer is interposed between each end plate and the adjacent end electrode. Each end electrode includes a single sheet of conductive material having a high specific surface area and sorption capacity. In the preferred embodiment, the sheet of conductive material is formed of carbon aerogel composite. The cell further includes a plurality of generally identical double-sided intermediate electrodes that are equidistally separated from each other, between the two end electrodes. As the electrolyte enters the cell, it flows through a continuous open serpentine channel defined by the electrodes, substantially parallel to the surfaces of the electrodes. By polarizing the cell, ions are removed from the electrolyte and are held in the electric double layers formed at the carbon aerogel surfaces of the electrodes. As the cell is saturated with the removed ions, the cell is regenerated electrically, thus significantly minimizing secondary wastes.
Patent DE-69603094-D1 (DE)
Inventor: RUDBECK POUL
IPC: F02C6/18
Filed: 1996-01-08
Granted: 1999-08-12
Abstract: Process for the generation of electrical power in a gas turbine cycle comprising an air compression stage (12), first (8) and second (10) gas combustion stages and a series of first (14) and second (16) gas expansion stage providing mechanical power for the generation of electrical power in a rotating power generator, the improvement of which comprises steps of operating the first combustion stage (8) on hydrogen depleted fuel gas at high pressure and air from the air compression stage, the hydrogen depleted fuel gas is obtained by endothermic catalytic steam reforming (2) of a hydrocarbon feed gas (20); supplying heat for the endothermic steam reforming (2) by indirect heat exchange with heat from hot exhaust gas from the second expansion stage (16); separating hydrogen enriched gas from the hydrogen depleted fuel gas during the catalytic steam reforming (2) of the feed gas (20); and operating the second combustion stage (10) at lower pressure than the first combustion stage (8) on exhaust gas from the first expansion stage (14) and the hydrogen enriched gas (28) being separated from the hydrogen depleted gas (30). <IMAGE>
Patent DE-69613575-D1 (DE)
Inventor: PEDERSEN KNUD KRISTIAN
IPC: B29C48/90
Filed: 1996-05-17
Granted: 2001-08-02
Abstract: PCT No. PCT/DK96/00220 Sec. 371 Date Nov. 17, 1997 Sec. 102(e) Date Nov. 17, 1997 PCT Filed May 17, 1996 PCT Pub. No. WO96/36475 PCT Pub. Date Nov. 21, 1996For calibration and stabilization of the discharge product from extruders it is known to use tubular calibration units both for calibration of the product diameter and for cooling of the product for initial stabilization of the product, whereby the calibration pipe should have a noticeable length. For a current exact calibration it may be desirable to effect small changes of the calibration diameter, yet with associated problem in exchanging the calibration pipe. The apparatus provides for a calibration pipe (14) with adjustable diameter, viz. in that the pipe is made of a number of split rings (16), which are juxtaposed with random locations of the splits (18), such that the pipe when seen in its axial direction is entirely unbroken. The rings (16) may be collectively radially compressed in a controlled manner by means of axially extending wedge clamp rods (24, 26) for a uniform adjustment of the diameter of the pipe (14) as a whole.
Patent DE-69615679-D1 (DE)
Inventor: MANDANAS Y
IPC: A61K8/81
Filed: 1996-05-23
Granted: 2001-11-08
Abstract: Preparation of a visually clear gel dentifrice comprising a precipitated silica polishing agent having a refractive index of about 1.44, a water-swellable synthetic anionic polycarboxylate polymer which is added in solid form and a liquid vehicle comprising water and sorbitol wherein (a) when the total water content is above 30% to about 33% by weight of said dentifrice, sorbitol on a neat basis is present in amount of above 30% to about 36% by weight of said dentifrice (b) when the total water content is about 27% up to below 30% by weight of said dentifrice, sorbitol on a neat basis is present in amount of about 20% up to below 30% by weight of said dentifrice and other humectant if present, is in neat amount of up to 15% by weight of said dentifrice and also adding to said liquid vehicle about 1-4% by weight of dentifrice of solid water-swellable synthetic anionic polycarboxylate polymer.
Patent DE-69618811-D1 (DE)
Inventor: KHATTAR RAJESH
IPC: C07C37/86
Filed: 1996-11-08
Granted: 2002-03-14
Abstract: A light colored basic alkali or alkaline earth metal organic salt is obtained by the reaction of a basic metal compound, an alkyl phenol and/or a carboxylic acid, carbon dioxide, and thereafter post-treating the reaction product with an organic phosphite. Alkaline earth metal salts of phenols and carboxylic acids include barium or calcium. Organic phosphites include trialkyl or dialkyl phosphites such as triisodecyl phosphite or diisooctyl phosphite.
Patent DE-69621562-D1 (DE)
Inventor: FANNEY DOUGLAS M
IPC: A61F9/007
Filed: 1996-11-11
Granted: 2002-07-11
Abstract: A surgical cassette adapter (10), comprising : a housing adapted to receive a surgical cassette (18); a means (28,30) contained within the housing for controlling irrigation and aspiration fluid flows within the cassette (18); and a communications port (34,36) connected to the means for controlling irrigation and aspiration fluid flows within the cassette (18). A surgical system comprising : a surgical console (12); a surgical cassette (18); and an adapter (10) that receives the surgical cassette (18) wherein the adapter (10) communicates with the surgical console (12) is also described. <IMAGE>
Patent DE-69623812-D1 (DE)
Inventor: MAITRE JEAN-PAUL
IPC: C13B50/00
Filed: 1996-12-04
Granted: 2002-10-24
Abstract: PCT No. PCT/FR96/01931 Sec. 371 Date Jul. 21, 1998 Sec. 102(e) Date Jul. 21, 1998 PCT Filed Dec. 4, 1996 PCT Pub. No. WO97/21838 PCT Pub. Date Jun. 19, 1997A composition containing sugar microcrystals is disclosed. Essentially, the crystals are uniform unbroken single crystals with a regular geometrical shape and a grain size following a Gaussian distribution of which the median is of around 20-220  mu m, while the coefficient of variation is of around 20-50%, particularly 30-45%, 35-45% or 30-40%. The term "sugar" designates mono-, di- and oligosaccharides, as well as the polyols obtained by their reduction.
Patent DE-69625359-D1 (DE)
Inventor: BHATIA B
IPC: A23L15/00
Filed: 1996-05-24
Granted: 2003-01-23
Abstract: The invention provides an egg product having a reduced amount of free water comprising at least 30 wt-% whole egg; glycerol; maltodextrin; egg white powder; powdered shortening; liquid egg yolk, and salt. This egg product has a Aw of about 0.80 to 0.95. Further, the invention provides food products comprising this egg product, including baked goods and other products having the egg product as a filling or topping, that may be frozen and reheated without the egg product developing a tough or rubbery texture.
Patent DE-69626554-D1 (DE)
Inventor: WATSON STEPHEN
IPC: C07D401/12
Filed: 1996-12-13
Granted: 2003-04-10
Abstract: The invention relates to a novel class of amide derivatives which act as thrombin inhibitors as described by formula (I), where R1 and R2, independently represent a group (a) or R1 and R2 together form a C3-7 heterocycloalkyl or heterocycloalkenyl group which may be optionally substituted by C1-6 alkyl, C1-4 alkoxy, halogen, carboxylic acid or a C1-4 carboxylic acid ester group; R3 represents hydrogen, C1-3 alkyl, halogen, or C1-2 alkoxy; R4, R5 and R6 independently represent hydrogen, or halogen; R7 represents hydrogen or C1-6 alkyl; R8 represents hydrogen, C3-7 cycloalkyl, C3-7 cycloalkenyl, C3-7 heterocycloalkyl, C3-7 heterocycloalkenyl, aryl or heteroaryl, which groups are optionally substituted by one or more groups selected from halogen, hydroxy, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 acyloxy, NR9R10, NHCOR11, NHSO2R12, COR13, CO2R14, CONR15R16, and SO2NHR17; X represents a bond, a C1-6 alkyl chain, or a C3-6 alkenyl chain, where one or two nitrogen, oxygen, or sulfur atoms may be optionally contained within each chain, and the chains are optionally substituted by one or more groups selected from halogen, hydroxy, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 acyloxy, NR9R10, NHCOR11, NHSO2R12, COR13, CO2R14, CONR15R16, and SO2NHR17; R9-R17 represent hydrogen, C1-6 alkyl, or R9 and R10 or R15 and R16 form a C</PDA
Patent DE-69632062-D1 (DE)
Inventor: CUTLER L
IPC: A61K47/48
Filed: 1996-10-31
Granted: 2004-05-06
Abstract: A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein the undesirable side effects normally associated with cytokine administration are diminished or eliminated. The method comprises continuously administering a low dose of a cytokine to an individual afflicted with a condition susceptible of treatment with the cytokine. In a preferred embodiment of the invention, chronic hepatitis C is treated by administering a low dose amount of interferon.
Patent DE-69632924-D1 (DE)
Inventor: POTTER R
IPC: A43B21/00
Filed: 1996-05-23
Granted: 2004-08-19
Abstract: A complex-contoured tensile bladder and method of making same in which a bladder comprises an envelope formed from two outer barrier layers surrounding a tensile element formed of two inner sheets. The inner sheets are attached to one another along selected first attachment portions and include die cuts at certain locations. Each of the outer barrier layers are attached to the inner sheet nearest it at selected second attachment portions which are incoincident with the selected first attachment portions. The outer layers are sealed around the periphery to form the envelope and the bladder is inflated with a gas so that the inner sheets form a tensile member which extends between the selected second portions, and the selected first portions form hinges disposed between the outer layers. When loaded the tensile member compresses at the hinges which readily allow for compression while not interfering with the cushioning properties of the gas. This construction of the bladder allows for the formation of complex-curved, contoured shapes by appropriately selecting the first attachment portions and the second attachment portions and the die cuts.
Patent DE-69710839-D1 (DE)
Inventor: AMON PHILIPPE
IPC: B41M3/14
Filed: 1997-04-25
Granted: 2002-04-11
Abstract: A bleeding or fugitive printing ink is disclosed and claimed which can be printed by the method of dry or wet offset or letterpress. This ink allows, when printed on security documents and dried, to prevent attempts of forgery or counterfeit in that the ink contains at least one dyestuff which is sensitive to organic solvents and other chemical reagents. The ink, when printed, forms a solid, polymerised or cross-linked binder matrix on the surface of the document when the printings are submitted to energy radiation, or by an oxypolymerisation reaction. This matrix is formed nearly immediately, in the case of oxypolymerisation within 24 hours, in contrast to conventional bleeding printing inks whose matrixes do not really dry and remain liquid in the interstices of the substrate.
Patent DE-69719334-D1 (DE)
Inventor: BRYNIARSKI A
IPC: A44B19/36
Filed: 1997-08-14
Granted: 2003-04-03
Abstract: A plastic bag comprises first and second opposing panels, a reclosable zipper (22), and a slider (32). The first and second opposing panels (12,14) are fixedly connected to each other along a pair of sides (16) and a bottom bridging the pair of sides. The reclosable zipper extends along a mouth (10) formed opposite the bottom. The zipper (22) includes a first track with a first profile (24) and a second track with a second profile (28). The first and second profiles are releasably engageable to each other. The slider (32) is slidably mounted to the zipper for movement between a closed position and an open position. The first and second profiles (24,28) are engaged to each other while the slider (32) is in the closed position, and the first and second profiles (24,28) are disengaged from each other in response to movement of the slider (32) from the closed position to the open position. To prevent the slider from going past the ends of the zipper and to provide adequate end strength that resists stresses applied to the profiles during normal use of the bag, end stops (36) in the form of flexible segments severed from a flexible plastic strip, fairly rigid segments severed from an extruded clip profile, or softened plastic material, are applied and secured to opposite ends of the zipper.
Patent DE-69720688-D1 (DE)
Inventor: GAVISH BENJAMIN
IPC: A61B5/113
Filed: 1997-01-21
Granted: 2003-05-15
Abstract: A system for modifying naturally occurring biorhythmic activity including: a monitor for analyzing biorhythmic activity of a user; a biorhythmic activity modifier for providing to the user a stimulus input which is operative to change at least one aspect of the biorhythmic activity of the user; a driver operative to control the operation of the biorhythmic activity modifier, so as to change at least one non-frequency characteristic of the input to the user, in response to changes in the biorhythmic activity of the user during operation of the modifier. A method for modifying naturally occurring biorhythmic activity is also described and claimed.
Patent DE-69721557-D1 (DE)
Inventor: RICHARDS GEOFFREY N
IPC: C08B37/00
Filed: 1997-11-20
Granted: 2003-06-05
Abstract: Arabinogalactan compositions are provided which are useful in a wide variety of different biomedical applications. In one embodiment, water soluble lipidated arabinogalactans are provided which include arabinogalactan with a limited proportion of lipophilic groups, such as long-chain hydrocarbon groups, covalently attached to free hydroxyl groups on the arabinogalactan. The lipidated arabinogalactans are water soluble and biocompatible and are useful for a wide variety of different biomedical applications. The lipidated arabinogalactans can be used, for example, to inhibit cell adhesion, and to inhibit infection or inflammation. The lipidated arabinogalactans further may be used as adjuvants, to inhibit metastasis, and in other therapeutic applications.
Patent DE-69733035-D1 (DE)
Title: Chimäres retrovirus/adenovirus system
Inventor: CURIEL T
IPC: C12N15/09
Filed: 1997-11-19
Granted: 2005-05-19
Abstract: The present invention provides a chimeric viral vector system having a highly efficient in vivo gene delivery to cells after vascular administration and an intergrative capacity of heterologous gene sequences for stable genetic modification of cells after transduction. In this chimeric vector, an adenoviral vector is employed to deliver retroviral functions to a cell for local, in situ production of retroviral particles inside the cell by the construction of replication-defective adenoviral vectors which contain either retroviral "packaging" functions (retroviral genes gag, pol, env) and retroviral "vector" functions (retroviral LTR sequences flanking the "therapeutic" gene).
Patent DE-69812644-D1 (DE)
Inventor: SHASTRI VENKATRAM R
IPC: A61L31/04
Filed: 1998-07-10
Granted: 2003-04-30
Abstract: Compositions for bone repair have been developed based on linear hydrophobic degradable polymers and monomers or macromers, at least one of which includes an anhydride linkage. The monomers and/or macromers crosslink each other but not to the linear polymer to form semi-interpenetrating networks. The compositions can include various excipients, therapeutic and/or diagnostic agents. The compositions can be polymerized in the presence of dissolvable particles such as inorganic salts and proteinaceous materials to provide a porous polymer network. The compositions can be injected into a patient and polymerized in situ or can be polymerized ex vivo and implanted. When polymerized ex vivo, the composition can be shaped into various articles, such as pins, screws, and hollow tubes, which can be used to repair broken bones.
Patent DE-69826025-D1 (DE)
Inventor: COOPER LARRY V
IPC: E21B17/00
Filed: 1998-10-21
Granted: 2004-10-07
Abstract: Apparatus for recovering logging tools and the like from a wellbore as part of a drilling operation such as for oil wells, irrigation systems and the like. The apparatus comprises the use of a flexible connector member (44) in the form of a flexible wire rope, or strand, or cable which is provided with socket members (46, 48 or 146, 148) attached with resin (54) or by being swaged or crimped to the flexible member (44). The apparatus takes the place of the conventional rigid sinker bar assembly that causes safety concerns when used with a top drive housing.
Patent DE-69826671-D1 (DE)
Inventor: TARTAKOVSKY ALLA
IPC: C11D3/37
Filed: 1998-07-13
Granted: 2004-11-04
Abstract: An automatic dishwashing machine detergent composition is described which contains an effective amount of a defined water soluble cationic or amphoteric polymer and a phosphate or nonphosphate builder. The polymers are soluble or dispersible to at least 0.01 % by weight in distilled water at 25  DEG C. A method of using the polymers to prevent fading or corrosion of dishware is also described.
Patent DE-69827972-D1 (DE)
Inventor: KOWALSKI R
IPC: A23L17/00
Filed: 1998-08-04
Granted: 2005-01-05
Abstract: The invention provides a process comprising:  combusting organic material to generate smoke, wherein said smoke contains taste compounds; purifying said smoke and treating meat with said smoke;  whereby said treated meat does not retain a smoky taste. <IMAGE> <IMAGE> <IMAGE>
Patent DE-69828414-D1 (DE)
Inventor: BERZOFSKY A
IPC: A61K39/02
Filed: 1998-09-11
Granted: 2005-02-03
Abstract: The invention provides methods for induction of an antigen-specific, mucosal cytotoxic T lymphocyte response useful in preventing and treating infections with pathogens that gain entry via a mucosal surface.
Patent DE-69832883-D1 (DE)
Inventor: MURAKAMI HIROSHI
IPC: C07K14/705
Filed: 1998-06-30
Granted: 2006-01-26
Abstract: Transgenic non-human mammals which have a human complement regulator (DAF/CD55) gene and in which this regulator has been expressed in the organs and tissues, in particular, vascular endothelial cells. These transgenic mammals are useful as laboratory animals in the fields of medicine, pharmacy, etc. and/or sources for organs, tissues, cells, etc. to be used in treating humans.
Patent DE-69833545-D1 (DE)
Inventor: RIESBECK KRISTIAN
IPC: H04W4/00
Filed: 1998-03-26
Granted: 2006-04-27
Abstract: The invention relates to the inhibition of blood coagulation, especially during organ rejection, and in particular the inhibition of delayed vascular rejection.  The invention provides anticoagulant proteins which are anchored to cell membranes. The anticoagulant function is preferably provided by heparin, antithrombin, hirudin, TFPI, tick anticoagulant peptide, or a snake venom factor.  These anticoagulant proteins are preferably prevented from being constitutively expressed at the cell surface. In particular, expression at the cell-surface is regulated according to cell-activation, for instance by targeting the protein to a suitable secretory granule.  Expression of these proteins renders cells, tissues and organs less vulnerable to rejection after transplantation (eg. after xenotransplantation).
Patent DE-69834124-D1 (DE)
Inventor: GRUZDEV A
IPC: F24H1/22
Filed: 1998-07-02
Granted: 2006-05-18
Abstract: An apparatus for heat generation includes a vessel (1) having a working chamber containing a working polar fluid (2). A source of pulsed light (3) and a light-reflecting surface (5) wettable by the working fluid are situated within the working chamber. A thermal energy is released into the working polar fluid by the pulsed light irradiation of the working fluid in the vicinity of the light-reflecting surface (5).
Patent DE-69900111-D1 (DE)
Inventor: QUERCIOLI ENRICO
IPC: B43K8/06
Filed: 1999-05-07
Granted: 2001-06-21
Abstract: A felt pen or a like writing instrument includes an elongate body (3) having a cavity defining a first chamber (15) housing a plug (14) of hydrophilic material associated with a writing tip (9) one end of which (9a) projects out of the body (3). The body (3) also includes a second chamber (25) separated from the first chamber (15) and defining a reservoir for liquid ink (26) for supplying the writing tip (9). The writing tip (9) is spaced from the second chamber (25) and can be supplied with ink directly from the plug (14) which draws ink from the reservoir through capillary supply means (24) independent of the writing tip (9) and interposed between the first and the second chambers (15, 25). <IMAGE>
Patent DE-69901389-D1 (DE)
Inventor: PETER SIEGFRIED
IPC: A61K39/00
Filed: 1999-05-11
Granted: 2002-06-06
Abstract: A process is described for extracting carotenes from carotene-containing materials, in particular from fats and oils of biological origin, which provides for extraction of carotene-containing material with an extractant comprising at least one member selected from the group consisting of acetonitrile, N-methylpyrrolidone, N,Ndimethylformamide, N,N-dimethylacetamide, 4-formylmorpholine, 4-acetylmorpholine, 4-methylmorpholine, 4-phenylmorpholine.
Patent DE-69914614-D1 (DE)
Inventor: LITERATI NAGY PETER
IPC: A61P3/00
Filed: 1999-09-02
Granted: 2004-03-11
Abstract: The object of the invention consists of novel unsaturated hydroximic acid derivatives, the process for their preparation and as active substance such as compounds containing pharmaceutical compositions. The novel compounds possess valuable pharmaceutical effects, so they can be used in the treatment of states connected with energy deficiency of the cell caused by PARP inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases. In formula (I).
Patent DE-69914934-D1 (DE)
Inventor: HAVELUND SVEND
IPC: A61K9/08
Filed: 1999-11-16
Granted: 2004-03-25
Abstract: Stable, aqueous insulin formulations without phenol and m-cresol which are suitable for pulmonary delivery and for delivery when phenol and m-cresol are undesirable are disclosed. The formulations provide increased convenience for the patient.
Patent DE-69916104-D1 (DE)
Inventor: LINDEMANN ERIC
IPC: H04R5/02
Filed: 1999-12-03
Granted: 2004-05-06
Abstract: A digital wireless loudspeaker system includes an audio transmission device for selecting and transmitting digital audio data, and wireless speakers for receiving the data and broadcasting sound. The audio transmission device selects digital audio data together with a sample clock from a stereo compact disk, or decoded DVD data. The sample clock clocks an element that generates frames of data and adds error protection. Status messages are included in the transmission frames to control speaker attributes such as speaker group, enabling or disabling a sub-woofer, and volume of the loudspeaker digitally. These transmission frames are clocked into an RF transmitter and transmitted to the speakers. The received bit stream and symbol clock are output from the RF receiver in each speaker and input to a framing and error protection decoder and a sample clock generator. The recovered audio sample data and sample clock are input to a digital to speaker input conversion and channel selector.